The goal of this study is to understand structure/function relationships in CFTR, the protein whose defect causes cystic fibrosis (CF). To do this, we will study the hydrophobic sector of this complex molecule, because this sector of CFTR is most closely associated with the Cl channel function absent in CF. Two broad questions will be asked. One set of experiments will identify elements important to Cl channel activity by implanting cysteine residues to serve as receptors for cysteine-specific reagents. The Cl channel function of such variants will be evaluated in Xenopus oocytes. Among variants that retain function, we will examine more closely those in which channel activity is irreversibly blocked by hydrophilic cysteine-modifying agents. Analysis of a pool of such candidate mutants should identify the subset of transmembrane segments surrounding the CFTR Cl channel and the specific residues lining the channel pore. To complement these studies, parallel experiments will use mutagenesis to identify residues that may interact as salt bridges in CFTR. The genesis of such work relates to conflicting reports regarding the role of two charged residues (E92 and K95) in the first transmembrane segment of CFTR. We believe the present data are resolved if these two interact with one another in a direct way. To test the hypothesis that an ion pair is functionally relevant in this and other areas, we will increase charge density by replacing the anionic partner with a cationic residue (and vice versa) and examine the phenotype of the variant CFTRs in oocytes. To determine whether the original residues interact with one another, we will then replace them, one at a time, with neutral amino acids. In these latter trials, direct evidence for a salt bridge will arise if function is found only when oppositely charged or neutral residues are present. Together, such experiments should add significantly to our understanding of the membrane domain of CFTR, leading to a better grasp of how the CFTR Cl channel functions and is regulated.

Project Start
1998-09-30
Project End
2000-08-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
5
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Guggino, William B (2004) The cystic fibrosis transmembrane regulator forms macromolecular complexes with PDZ domain scaffold proteins. Proc Am Thorac Soc 1:28-32
Ketchum, Christian J; Rajendrakumar, Garnepudi V; Maloney, Peter C (2004) Characterization of the adenosinetriphosphatase and transport activities of purified cystic fibrosis transmembrane conductance regulator. Biochemistry 43:1045-53
Cheng, Jie; Wang, Hua; Guggino, William B (2004) Modulation of mature cystic fibrosis transmembrane regulator protein by the PDZ domain protein CAL. J Biol Chem 279:1892-8
Swiatecka-Urban, Agnieszka; Duhaime, Marc; Coutermarsh, Bonita et al. (2002) PDZ domain interaction controls the endocytic recycling of the cystic fibrosis transmembrane conductance regulator. J Biol Chem 277:40099-105
Cheng, Jie; Moyer, Bryan D; Milewski, Michal et al. (2002) A Golgi-associated PDZ domain protein modulates cystic fibrosis transmembrane regulator plasma membrane expression. J Biol Chem 277:3520-9
Ketchum, Christian J; Yue, Hongwen; Alessi, Karen A et al. (2002) Intracellular cysteines of the cystic fibrosis transmembrane conductance regulator (CFTR) modulate channel gating. Cell Physiol Biochem 12:1-8
Norlin, A; Lu, L N; Guggino, S E et al. (2001) Contribution of amiloride-insensitive pathways to alveolar fluid clearance in adult rats. J Appl Physiol 90:1489-96
Ketchum, C J; Schmidt, W K; Rajendrakumar, G V et al. (2001) The yeast a-factor transporter Ste6p, a member of the ABC superfamily, couples ATP hydrolysis to pheromone export. J Biol Chem 276:29007-11
Mickle, J E; Milewski, M I; Macek Jr, M et al. (2000) Effects of cystic fibrosis and congenital bilateral absence of the vas deferens-associated mutations on cystic fibrosis transmembrane conductance regulator-mediated regulation of separate channels. Am J Hum Genet 66:1485-95
Moyer, B D; Duhaime, M; Shaw, C et al. (2000) The PDZ-interacting domain of cystic fibrosis transmembrane conductance regulator is required for functional expression in the apical plasma membrane. J Biol Chem 275:27069-74

Showing the most recent 10 out of 39 publications